Showing results (11-20 of 62) with videos related to
Sort By:
Pageof 7
Plos One|November 1, 2019
BDNF, NT-3 and Trk receptor agonist monoclonal antibodies promote neuron survival, neurite extension, and synapse restoration in rat cochlea ex vivo models relevant for hidden hearing lossStephanie Szobota, Pranav D Mathur, Sairey Siegel, et al.Journal of Medicinal Chemistry|July 23, 2004
Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonistsChen Chen, Jinghua Yu, Beth A Fleck, et al.The Journal of Pharmacology and Experimental Therapeutics|September 2, 2018
Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual DysfunctionYong-Xin Li, Jia-Ying Yang, Miguel Alcantara, et al.Neurogenetics|March 31, 2006
Gene expression analyses reveal molecular relationships among 20 regions of the human CNSRichard B Roth, Peter Hevezi, Jerry Lee, et al.Molecular Pharmacology|September 2, 2021
Therapeutic Neuroprotection by an Engineered Neurotrophin that Selectively Activates Tropomyosin Receptor Kinase (Trk) Family Neurotrophin Receptors but Not the p75 Neurotrophin ReceptorFouad Brahimi, Alba Galan, Sairey Siegel, et al.The Journal of Pharmacology and Experimental Therapeutics|July 17, 2004
Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptorSusan K Sullivan, Robert E Petroski, Gail Verge, et al.The Journal of Pharmacology and Experimental Therapeutics|January 10, 2006
Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptorsRobert E Petroski, Jordan E Pomeroy, Ronnie Das, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 4, 2003
Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivoKenneth B Mackay, Sarah A Loddick, Gregory S Naeve, et al.Neuropharmacology|August 16, 2017
Phenylglycine analogs are inhibitors of the neutral amino acid transporters ASCT1 and ASCT2 and enhance NMDA receptor-mediated LTP in rat visual cortex slicesAlan C Foster, Natalie Rangel-Diaz, Ursula Staubli, et al.The European Journal of Neuroscience|September 3, 2004
Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditionsGail M Verge, Erin D Milligan, Steve F Maier, et al.Pageof 7